Bioengineered nanogels for cancer immunotherapy
Recent years have witnessed increasingly rapid advances in nanocarrier-based
biomedicine aimed at improving treatment paradigms for cancer. Nanogels serve as …
biomedicine aimed at improving treatment paradigms for cancer. Nanogels serve as …
Nanogels: Synthesis, properties, and recent biomedical applications
Nanogels, also termed hydrogel nanoparticles, have the properties and functions of both
nanomaterials and hydrogels. Till date, a considerable number of nanogels have been …
nanomaterials and hydrogels. Till date, a considerable number of nanogels have been …
Bioorthogonal-activated in situ vaccine mediated by a COF-based catalytic platform for potent cancer immunotherapy
Personalized tumor vaccines have become a promising modality for cancer immunotherapy.
However, in situ personalized tumor vaccines generated from immunogenic cancer cell …
However, in situ personalized tumor vaccines generated from immunogenic cancer cell …
Responsive biomaterials: optimizing control of cancer immunotherapy
Immunotherapy has emerged as an eminent and effective modality in the treatment of
cancer. However, current cancer immunotherapies lack spatial and temporal control …
cancer. However, current cancer immunotherapies lack spatial and temporal control …
Bioorthogonal activation of TLR7 agonists provokes innate immunity to reinforce aptamer-based checkpoint blockade
Y Wei, G Qin, Z Wang, C Zhao, J Ren, X Qu - ACS nano, 2023 - ACS Publications
Although cancer immunotherapy based on immune checkpoint blockade has shown
promising clinical responses, the limited host response rate and systemic side effects still …
promising clinical responses, the limited host response rate and systemic side effects still …
Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance
D Muraoka, N Harada, H Shiku, K Akiyoshi - Journal of Controlled Release, 2022 - Elsevier
In therapeutic cancer vaccines, vaccine antigens must be efficiently delivered to the antigen-
presenting cells (dendritic cells and macrophages) located in the lymphoid organs (lymph …
presenting cells (dendritic cells and macrophages) located in the lymphoid organs (lymph …
Ferrocene‐based polymeric nanoparticles carrying doxorubicin for oncotherapeutic combination of chemotherapy and ferroptosis
J Lin, H Yang, Y Zhang, F Zou, H He, W Xie, Z Zou… - Small, 2023 - Wiley Online Library
Mono‐chemotherapy has significant side effects and unsatisfactory efficacy, limiting its
clinical application. Therefore, a combination of multiple treatments is becoming more …
clinical application. Therefore, a combination of multiple treatments is becoming more …
Endogenous stimuli-responsive nanoparticles for cancer therapy: from bench to bedside
F Xie, M Wang, Q Chen, T Chi, S Zhu, P Wei… - Pharmacological …, 2022 - Elsevier
Cancer is complicated to treat because of its high propensity for recurrence and metastasis,
and various side effects of conventional cancer treatments. With the development of …
and various side effects of conventional cancer treatments. With the development of …
Polymerizable 2-propionic-3-methylmaleic anhydrides as a macromolecular carrier platform for PH-responsive immunodrug delivery
AG Heck, J Stickdorn, LJ Rosenberger… - Journal of the …, 2023 - ACS Publications
The design of functional polymers coupled with stimuli-triggered drug release mechanisms
is a promising achievement to overcome various biological barriers. pH trigger methods …
is a promising achievement to overcome various biological barriers. pH trigger methods …
pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages
L Kaps, A Huppertsberg… - Proceedings of the …, 2022 - National Acad Sciences
Immune-suppressive (M2-type) macrophages can contribute to the progression of cancer
and fibrosis. In chronic liver diseases, M2-type macrophages promote the replacement of …
and fibrosis. In chronic liver diseases, M2-type macrophages promote the replacement of …